Skip to main content

Theophylline and Related Xanthines

  • Chapter
Respiratory Disease

Part of the book series: Treatment in Clinical Medicine ((TC MEDICINE))

  • 146 Accesses

Abstract

The name theophylline (“divine leaf”) refers to the leaves of the tea plant which contain a small amount of theophylline. Naturally occurring methylxanthines also include theobromine found in cocoa and caffeine found in coffee beans, cocoa and cola nuts. Methylxanthines cause central nervous system stimulation, an observation traditionally attributed to an Arabian shepherd who noticed that goats played all night after eating berries of the coffee plant. Theophylline was extracted from tea leaves in 1888, its formula identified in 1895 and its bronchodilator action in animals established early this century. Although its potential value as a bronchodilator for asthma was noted in 1921, it was not evaluated systematically until the late 1930s when it came into more general use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Useful References

  • Cushley M, Holgate ST (1984) Theophylline. In: Buckle DR, Smith H (eds) Development of anti-asthma drugs. Butterworths, London, pp 205–223

    Google Scholar 

  • Dahlqvist R, Billing B, Ripe E (1984) Theophylline — clinical pharmacokinetics and therapeutic drug monitoring. Eur J Resp Dis 65 (Suppl. 136): 81–94

    Google Scholar 

  • Ebden P, Leopold D, Buss D, Smith AP, Routledge PA (1985) Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction. Thorax 40: 526–529

    Article  PubMed  CAS  Google Scholar 

  • Isles AF, MacLeod SM, Levison H (1982) Theophylline. New thoughts about an old drug. Chest 1: 49S - 54S

    Google Scholar 

  • Mountain RD, Neff TA (1984) Oral theophylline intoxication. A serious error of patient and physician understanding. Arch Intern Med 144: 724–727

    Article  PubMed  CAS  Google Scholar 

  • Moxham J, Green M (1985) Aminophylline and the respiratory muscles. Bull Eur Physiopath Resp 21: 1–6

    CAS  Google Scholar 

  • Persson CGA (1983) The profile of action of enprofylline, or why adenosine antagonism seems less desirable with xanthine antiasthmatics. In: Morley J, Rainsford KD (eds) Pharmacology of asthma, agents and actions, supplement 13. Birkhäuser Verlag, Basel

    Google Scholar 

  • Rhind GB, Connaughton JJ, McFie J, Douglas NJ, Flenley DC (1985) Sustained release choline theophyllinate in nocturnal asthma. Br Med J 291: 1605–1607

    Article  CAS  Google Scholar 

  • Vaughan LM, Weinberger MM, Milavetz G, Tillson S, Ellis E, Jenne J, Szefler SJ, Wiener MB, Conboy K, Shaughnessy T, Carrico J (1986) Multicentre evaluation of disposable visual measuring device to assay theophylline from capillary blood sample. Lancet I: 184–185

    Article  PubMed  CAS  Google Scholar 

  • Weinberger M, Hendeles L (1983) Slow release theophylline. Rationale and basis for product selection. N Engl J Med 308: 760–764

    Article  PubMed  CAS  Google Scholar 

  • Woodcock AA, Johnson MA, Geddes DM (1983) Theophylline prescribing, serum concentrations, and toxicity. Lancet II: 610–612

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tattersfield, A.E., McNicol, M.W. (1987). Theophylline and Related Xanthines. In: Respiratory Disease. Treatment in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-3132-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3132-8_17

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-16209-4

  • Online ISBN: 978-1-4471-3132-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics